Literature DB >> 18776721

Initiation of glucose-based peritoneal dialysis is associated with increased prevalence of metabolic syndrome in non-diabetic patients with end-stage renal disease.

Na Jiang1, Jiaqi Qian, Aiwu Lin, Bengt Lindholm, Jonas Axelsson, Qiang Yao.   

Abstract

BACKGROUND: Glucose-based peritoneal dialysis (PD) is the original PD form. However, glucose uptake from the peritoneal cavity may contribute to dysmetabolism.
METHODS: We retrospectively assessed metabolic syndrome (MS) and its components in 195 non-diabetic incident PD patients at baseline and after 34.3 (20.5-60.0) months of PD. MS was defined according to the Adult Treatment Panel III criteria.
RESULTS: While 22.1% of the patients met MS criteria at baseline, 69.2% (p < 0.01) exhibited MS during PD. MS burden increased significantly after PD (p < 0.01). The disorder BMI and lipids, and MS components number, correlated with peritoneal glucose exposure and PD duration (p < 0.05). In Cox analysis, age, BMI, triglyceride, C-reactive protein (CRP) and glucose exposure were all independently associated with MS development.
CONCLUSIONS: PD commencement in end-stage renal disease patients was associated with an increased MS prevalence. High glucose exposure and long PD duration were associated with MS existence, along with old age, high BMI, triglyceride and CRP. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18776721     DOI: 10.1159/000153248

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  15 in total

1.  Metabolic syndrome in peritoneal dialysis patients: choice of diagnostic criteria and prognostic implications.

Authors:  Cheuk-Chun Szeto; Bonnie Ching-Ha Kwan; Kai-Ming Chow; Chi-Bon Leung; Mei-Shan Cheng; Man-Ching Law; Philip Kam-Tao Li
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 8.237

2.  Dietary phosphorus intake and distribution in Chinese peritoneal dialysis patients with and without hyperphosphatemia.

Authors:  Na Jiang; Wei Fang; Xiaoxiao Yang; Lin Zhang; Jiangzi Yuan; Aiwu Lin; Zhaohui Ni; Jiaqi Qian
Journal:  Clin Exp Nephrol       Date:  2014-09-05       Impact factor: 2.801

Review 3.  The Current State of Peritoneal Dialysis.

Authors:  Rajnish Mehrotra; Olivier Devuyst; Simon J Davies; David W Johnson
Journal:  J Am Soc Nephrol       Date:  2016-06-23       Impact factor: 10.121

4.  Longitudinal Trend in Lipid Profile of Incident Peritoneal Dialysis Patients is Not Influenced by the Use of Biocompatible Solutions.

Authors:  Yeoungjee Cho; Janine Büchel; Sonja Steppan; Jutta Passlick-Deetjen; Carmel M Hawley; Goce Dimeski; Margaret Clarke; David W Johnson
Journal:  Perit Dial Int       Date:  2015-10-01       Impact factor: 1.756

5.  Relationship between glucose exposure via peritoneal dialysis solutions and coronary artery calcification in non-diabetic peritoneal dialysis patients.

Authors:  Ebru Sevinc Ok; Gulay Asci; Fatih Kircelli; Soner Duman; Hamad Dheir; Meltem Sezis Demirci; Mehmet Ozkahya; Huseyin Toz; Ercan Ok
Journal:  Int Urol Nephrol       Date:  2012-02-18       Impact factor: 2.370

6.  Incremental peritoneal dialysis allows to reduce the time spent for dialysis, glucose exposure, economic cost, plastic waste and water consumption.

Authors:  Luca Nardelli; Antonio Scalamogna; Elisa Cicero; Giuseppe Castellano
Journal:  J Nephrol       Date:  2022-09-20       Impact factor: 4.393

Review 7.  [Peritoneal dialysis from the beginnings up to today: which developments of the last decades were important?].

Authors:  Andreas Vychytil
Journal:  Wien Med Wochenschr       Date:  2013-04-17

8.  Randomized controlled trial of icodextrin versus glucose containing peritoneal dialysis fluid.

Authors:  Aiwu Lin; Jiaqi Qian; Xiaomei Li; Xueqing Yu; Wenhu Liu; Yang Sun; Nan Chen; Changlin Mei
Journal:  Clin J Am Soc Nephrol       Date:  2009-10-01       Impact factor: 8.237

9.  Aliskiren prevents the toxic effects of peritoneal dialysis fluids during chronic dialysis in rats.

Authors:  Juan Pérez-Martínez; Francisco C Pérez-Martínez; Blanca Carrión; Jesús Masiá; Agustín Ortega; Esther Simarro; Syong H Nam-Cha; Valentín Ceña
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

Review 10.  Insulin resistance in cardiovascular disease, uremia, and peritoneal dialysis.

Authors:  Mark Lambie; Mario Bonomini; Simon J Davies; Domenico Accili; Arduino Arduini; Victor Zammit
Journal:  Trends Endocrinol Metab       Date:  2021-07-12       Impact factor: 10.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.